Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 44 days ( -2,342.24 % )
Last Price $11.10 0 %
High/ Low $11.10 - $11.10 0%
Chg 7 Days N/A $11.10 $11.10
Chg 30 Days N/A $11.10 $11.10
Chg 12 mos 1,866.34 % $0.565 $11.10
Trend - 3 mos 73.61 % Width: 282.10 %
Trend - 12 mos 58.71 % Width: 1,687.96 %
Pred. range - 3 mos $14.14 - $54.02 27.37 % - 386.66 %
Pred. range - 12 mos $2.11 - $37.65 -81.03 % - 239.20 %
Short MA avg 3 mos Sell Mar 21, 2024 - 37 days
Long MA avg 3 mos Sell May 01, 2024 - 10 days
Short/Long MA avg 3 mos Sell May 01, 2024 - 10 days
Short MA avg 12 mos Sell Apr 10, 2024 - 24 days
Long MA avg 12 mos Buy Mar 11, 2024 - 45 days
Short/Long MA avg 12 mos Buy Mar 14, 2024 - 42 days
Pivot Short Buy Mar 26, 2024 - 34 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About AgeX Therapeutics, Inc.

AgeX Therapeutics. AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-base... AGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT